Healthcare provider profile · identity verified

Judith C Becher, MD

Internal Medicine · PORTLAND, OR · NPI 1114055258

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	497	119
Amlodipine Besylate	Amlodipine Besylate	296	76
Lisinopril	Lisinopril	255	64
Gabapentin	Gabapentin	242	47
Omeprazole	Omeprazole	228	58
Losartan Potassium	Losartan Potassium	183	47
Metoprolol Succinate	Metoprolol Succinate	176	36
Rosuvastatin Calcium	Rosuvastatin Calcium	165	46
Metformin Hcl	Metformin Hcl	163	33
Albuterol Sulfate Hfa	Albuterol Sulfate	140	39
Furosemide	Furosemide	139	26
Potassium Chloride	Potassium Chloride	112	23
Carvedilol	Carvedilol	111	17
Metformin Hcl Er	Metformin Hcl	104	30
Fluoxetine Hcl	Fluoxetine Hcl	103	15
Hydralazine Hcl	Hydralazine Hcl	98	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	98	22
Tamsulosin Hcl	Tamsulosin Hcl	98	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	92	13
Trazodone Hcl	Trazodone Hcl	89	23
Levothyroxine Sodium	Levothyroxine Sodium	86	20
Duloxetine Hcl	Duloxetine Hcl	78	21
Fluticasone Propionate	Fluticasone Propionate	65	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	59	14
Chlorthalidone	Chlorthalidone	58	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	56	suppressed
Baclofen	Baclofen	55	14
Jardiance	Empagliflozin	52	14
Mirtazapine	Mirtazapine	52	suppressed
Sertraline Hcl	Sertraline Hcl	51	15
Pregabalin	Pregabalin	48	11
Mounjaro	Tirzepatide	46	suppressed
Oxycodone Hcl	Oxycodone Hcl	44	12
Allopurinol	Allopurinol	43	suppressed
Montelukast Sodium	Montelukast Sodium	43	suppressed
Trulicity	Dulaglutide	42	suppressed
Eliquis	Apixaban	41	14
Prazosin Hcl	Prazosin Hcl	41	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	39	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	37	12
Propranolol Hcl	Propranolol Hcl	35	suppressed
Aripiprazole	Aripiprazole	34	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Glipizide	Glipizide	34	suppressed
Ezetimibe	Ezetimibe	33	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	33	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	32	suppressed
Famotidine	Famotidine	32	11
Metoprolol Tartrate	Metoprolol Tartrate	32	suppressed
Torsemide	Torsemide	32	suppressed
Pravastatin Sodium	Pravastatin Sodium	31	13
Diclofenac Sodium	Diclofenac Sodium	29	12
Escitalopram Oxalate	Escitalopram Oxalate	28	suppressed
Nifedipine Er	Nifedipine	28	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Atenolol	Atenolol	27	suppressed
Finasteride	Finasteride	27	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	27	suppressed
Dapagliflozin	Dapagliflozin Propanediol	26	suppressed
Divalproex Sodium	Divalproex Sodium	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Glipizide Er	Glipizide	25	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	25	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Nitroglycerin	Nitroglycerin	22	12
Olanzapine	Olanzapine	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Simvastatin	Simvastatin	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	suppressed
Atrovent Hfa	Ipratropium Bromide	20	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Humulin N	Insulin Nph Human Isophane	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	17	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Lactulose	Lactulose	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Methimazole	Methimazole	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Doxepin Hcl	Doxepin Hcl	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Spiriva Respimat	Tiotropium Bromide	16	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Bydureon Bcise	Exenatide Microspheres	12	suppressed
Calcitriol	Calcitriol	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Diazepam	Diazepam	12	suppressed
Estradiol	Estradiol	12	suppressed
Haloperidol	Haloperidol	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	12	suppressed
Xifaxan	Rifaximin	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Citalopram Hbr	Citalopram Hydrobromide	11	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Primidone	Primidone	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Tiotropium Bromide	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error